Increasing cancer incidence increases the demand for drug delivery systems. This will likely contribute significantly to the market's growth during the forecast period. Technological Advancements ...

Medicare spending on cancer drugs may not be associated with the drugs’ clinical benefits, such as overall survival or progression-free survival.

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...

Hydrogel Market The demand for hydrogels grows due to rising needs in wound care, drug delivery, agriculture, and increased awareness of ...

An analysis of oncology drugs approved in the United States found that Medicare spending was predominantly driven by the market, not a drug’s therapeutic value.

Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Request To Download Free Sample of This Strategic Report @ Catalysts of Market Growth: The buoyant growth trajectory of the global monoclonal antibodies market is propelled by a convergence of ...

Sri Lanka’s attempt to emulate India’s pharmaceutical pricing system is a cautionary tale of misplaced ambition ...

The study included nearly 2 million patients, making it the largest ever conducted on this group of glucagon-like peptide-1 ...

The J&J deal would be the biggest biotech deal in over a year and will add treatments for disorders of the central nervous ...

The Theranostics Market is poised for remarkable expansion, as indicated by the latest report from Report Ocean. Theranostics, an emerging field at the intersection of diagnostics and therapy, is ...